Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells

Biomedicine and Preventive Nutrition

Volumn 1, Issue 4, 2011, Pages 223-231

  Krishnakumar, Narendran ^a   Sulfikkarali, Nechikkad ^a   RajendraPrasad, Nagarajan ^a   Karthikeyan, Subburayan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Anticancer effect; HeLa cells; Nanoparticles; Naringenin

Indexed keywords

GLUTATHIONE; NANOPARTICLE; NARINGENIN; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG POTENCY; DRUG RELEASE; DRUG STRUCTURE; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION;

EID: 83655191635     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2011.09.003     Document Type: Article

References (47)

1. Mohanty C., Sahoo S.K. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 2010, 31:6597-6611.
2. Feng S.S., Chien S. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem Eng Sci 2003, 58:4087-4114.
3. Sur Y.J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003, 3:768-780.
4. Link A., Balaguer F., Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmcol 2010, 80:1771-1792.
5. Tripoli E., Guardia M.L., Giammanco S., Danila D., Majo D., Giammanco M. Citrus flavonoids: molecular structure, biological activity and nutritional properties: a review. Food Chem 2007, 104:466-479.
6. Manthey J.A., Grohmann K., Guthrie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem 2001, 8:135-153.
7. Amaro M.I., Helder Vila-Real J.R., Eduardo-Figueira M., Mota- Filipe H., Sepodes B., Ribeiro M.H. Anti-inflammatory activity of naringin and the biosynthesised naringenin by naringinase immobilized in microstructured materials in a model of DSS-induced colitis in mice. Food Res Int 2009, 42:1010-1017.
8. Choi J.S., Park K.Y., Moon S.H., Rhee S.H., Young H.S. Antimutagenic effect of plant flavonoids in the salmonella assay system. Arch Pharm Res 1994, 17:71-75.
9. Lee C.H., JeongTS, Choi Y.K., Hyun B.H., Oh G.T., Kim E.H., et al. Antiatherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophy Res Commun 2001, 284:681-688.
10. Renugadevi J., Milton Prabu S. Cadmium- induced hepatotoxicity in rats and protective effect of naringenin. Exp Toxicol Pathol 2010, 62:171-181.
11. Ekambaram G., Rajendran P., Magesh V., Sakthisekaran D. Naringenin reduces tumor size and weight loss in N-methyl-N-nitro-N-nitrosoguanidine- induced gastric carcinogenesis in rats. Nutr Res 2008, 28:106-112.
12. Van Acker F.A.A., Schouten O., Haenen G.R., Van Dervijgh W.J.F., Bast A. Flavonoids can replace α-tocopherol as an antioxidant. FEBS Lett 2000, 473:145-148.
13. Kanno S., Tomizawa A., Ohtake T., Koiwai K., Ujibe M., Ishikawa M. Naringenin- induced apoptosis via activation of NF-Kappa B and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett 2006, 166:131-139.
14. Wang B.D., Yang Z.Y., Wang Q., Cai T.K., Crewdson P. Synthesis, characterization, cytotoxic activities and DNA-binding properties of the La(III) complex with naringenin schiff-base. Bioorg Med Chem 2006, 14:1880-1888.
15. Yen F.L., Wu T.H., Lin L.T., Cham T.M., Lin C.C. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effect of naringenin in orally administrated rats with CCl4-induced acute liver failure. Pharm Res 2008, 26:893-902.
16. Ratnam D.V., Ankola D.D., Baradwaj V., Sahana D.K., Ravikumar M.N.V. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 2006, 113:189-207.
17. Wen J., Liu B., Yuan E., Ma Y., Zhu Y. Preparation and physiochemical properties of the complex of naringenin with hydroxypropyl-β-cyclodextrin. Molecules 2010, 15:4401-4407.
18. Semalty A., Semalty M., Singh D., Rawat M.S.M. Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J Incl Phenom Macrocycl Chem 2010, 67:253-260.
19. Jain A.K., Swarnakar N.K., Godugu C., Singh R.P., Jain S. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials 2011, 32:503-515.
20. Haixiong G., Yong H., Jaing X., Cheng D., Yuan Y., Bi H., et al. Preparation, characterization and drug release behaviors of drug nimodipine-loaded poly (e{open}-caprolactone)-poly (ethylene oxide)-poly (e{open}-caprolactone) amphilic triblock copolymer micelles. J Pharm Sci 2002, 91:1463-1473.
21. Acharya S., Sahoo S.K. PLGA nanoparticles containing various anticancer agents and tumor delivery by EPR effect. Adv Drug Del 2001, 63:170-183.
22. Jung J.Y., Yoo S.D., Lee S.H., Kim K.H., Yoon D.S., Lee K.H. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int J Pharm 1999, 187:209-218.
23. Wang S.L., Lin S.Y., Chen T.F., Cheng W.T. Eudragit E accelerated the diketopiperazine formation of enalapril maleate determined by thermal FT-IR microspectroscopic technique. Pharm Res 2004, 21:2127-2132.
24. Moshmann T. Rapid calorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Method 1983, 65:55-63.
25. Hafer K., Iwamoto K.S., Schiestl R.H. Refinement of the dichlorofluorescein assay for flow cytometric measurement of reactive oxygen species in irradiated and by stander cell populations. Radiat Res 2008, 169:460-468.
26. Bhosle S.M., Huilgol N.G., Mishra K.P. Enhancement of radiation-induced oxidative stress and cytotoxicity in tumor cells by ellagic acid. Clin Chim Acta 2005, 359:89-100.
27. Rajendra Prasad N., Karthikeyan A., Karthikeyan S., Venkata Reddy B. Inhibitory effect of caffeic acid on cancer proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line. Mol Cell Biochem 2010, 34:11-19.
28. Niehaus W.G., Samuelsson B. Formation of malondialdehyde from phospholipids arachidonale during microsomal lipid peroxidation. Eur J Biochem 1968, 210:486-489.
29. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
30. Sahu S.K., Mallick S.K., Santra S., Maiti T.K., Ghosh S.K., Pramanik P. In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. J Mater Sci Mat Med 2010, 21:1587-1597.
31. Misra R., Sahoo S.K. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. Eur J Pharm Sci 2010, 39:152-163.
32. Li X., Zhen D., Lu X., Xu H., Shao Y., Xue Q., et al. Enhanced cytotoxicity and activation of ROS dependent c-Jun NH2-terminal kinase and caspase-3 by low doses of terandrine-loaded nanoparticles in Lovo cells - a possible Trojan strategy against cancer. Eur J Pharm Bio Pharm 2010, 75:334-340.
33. Sanoj Rejinold N., Muthunarayanan M., Chennazhi K.P., Nair S.V., Jayakumar R. 5-Fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications. Int J Biol Macromol 2010, 48:98-105.
34. Laurent C., Nicco C., Chereau C., Goulvestre C., Alexandre J., Alves A., et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Can Res 2005, 65:948-956.
35. Ulbrich K., Michaelis M., Rothweiler F., Knobloch T., Sithisarn P., Cinatl J., et al. Interaction of folate-conjugate human serum albumin (HSA) nanoparticle with tumour cells. Int J Pharm 2011, 406:128-134.
36. Tosi G., Costantino L., Ruozi B., Forni F., Vandelli M.A. Polymeric nanoparticle for the drug delivery to the central nervous system. Expert Opin Drug Deliv 2008, 5:155-174.
37. Hsiu S.L., Huang T.Y., Hou Y.C., Chin D.H., Chao P.D. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits. Life Sci 2002, 70:1481-1489.
38. Maeda H., Wu J., Sawa T., Matsumura Y., Flori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Controlled Release 2000, 65:271-284.
39. Praveen S., Sahoo S.K. Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastoma. Cancer Nano 2010, 1:47-62.
40. Das M., Sahoo S.K. Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy. Acta Biomaterialia 2010, 7:355-369.
41. Sahoo S.K., Labhestwar V. Enhanced antiproliferative activity of transferrin conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm 2005, 2:373-383.
42. Shao J., Li X., Lu X., Jiang C., Hu Y., Li Q., et al. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloid Surface B Bio Interface 2009, 72:40-47.
43. Luo H., Li J., Chen X. Antitumor effect of N-succinyl-chitosan nanoparticles on K562 cells. Biomed Pharmacother 2009, 64:521-526.
44. Binggeli R., Weinsten R.C. Membrane potentials and sodium channels: hypotheses for growth regulation and cancer formation based on changes in sodium channels and gap junctions. J Theor Biol 1986, 123:377-401.
45. De Berrardis B., Civitelli G., Condello M., Lista P., Pozzi R., Arancia G., et al. Exposure to ZnO nanoparticles induces oxidative stress and cytotoxicity in human colon carcinoma cells. Toxicol Appl Pharm 2010, 246:116-127.
46. Park J.W., Lee J.W., Paik H.D., Cho S.G., Nah S.Y., Park Y.S., et al. Cytotoxic effect of 7-Obutyl naringenin on human breast cancer MCF-7 cells. Food Sci Biotechnol 2010, 19:717-724.
47. Chang H., Mi M., Ling W., Zhu J., Zhang Q., Wei Q., et al. Structurally related cytotoxic effect of flavonoids on human cancer cells in vitro. Arch Pharm Res 2008, 31:1137-1144.